Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

379 ARTÍCULOS , VIENDO DEL 211 AL 225

Humanin: a possible linkage between Alzheimer's disease and type 2 diabetes

Mahboobi H, Golmirzaei J, Gan SH, Jalalian M, Kamal MA.

CNS Neurol Disord Drug Targets. 2014 Apr;13(3):543-52. doi: 10.2174/1871527312666131223110147.

Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study

Camargos EF, Louzada LL, Quintas JL, Naves JO, Louzada FM, Nóbrega OT.

Am J Geriatr Psychiatry. 2014 Dec;22(12):1565-74. doi: 10.1016/j.jagp.2013.12.174. Epub 2014 Jan 4.

Differences in nutritional status between very mild Alzheimer's disease patients and healthy controls

Olde Rikkert MG, Verhey FR, Sijben JW, Bouwman FH, Dautzenberg PL, Lansink M, Sipers WM, van Asselt DZ, van Hees AM, Stevens M, Vellas B, Scheltens P.

J Alzheimers Dis. 2014;41(1):261-71. doi: 10.3233/JAD-131892.

Differences in routine clinical practice between early and late onset Alzheimer's disease: data from the Swedish Dementia Registry (SveDem)

Eriksson H, Fereshtehnejad SM, Falahati F, Farahmand B, Religa D, Eriksdotter M.

J Alzheimers Dis. 2014;41(2):411-9. doi: 10.3233/JAD-132273.

Beyond acetylcholinesterase inhibitors for treating Alzheimer's disease: α7-nAChR agonists in human clinical trials

Russo P, Del Bufalo A, Frustaci A, Fini M, Cesario A.

Curr Pharm Des. 2014;20(38):6014-21. doi: 10.2174/1381612820666140316130720.

Retrospective study on the benefits of combined Memantine and cholinEsterase inhibitor treatMent in AGEd Patients affected with Alzheimer's Disease: the MEMAGE study

Gareri P, Putignano D, Castagna A, Cotroneo AM, De Palo G, Fabbo A, Forgione L, Giacummo A, Lacava R, Marino S, Simone M, Zurlo A, Putignano S.

J Alzheimers Dis. 2014;41(2):633-40. doi: 10.3233/JAD-132735.

Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine

Zemek F, Drtinova L, Nepovimova E, Sepsova V, Korabecny J, Klimes J, Kuca K.

Expert Opin Drug Saf. 2014 Jun;13(6):759-74. doi: 10.1517/14740338.2014.914168.

Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease

Yarchoan M, Arnold SE.

Diabetes. 2014 Jul;63(7):2253-61. doi: 10.2337/db14-0287. Epub 2014 Jun 15.

Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients

Mokhber N, Abdollahian E, Soltanifar A, Samadi R, Saghebi A, Haghighi MB, Azarpazhooh A.

Pharmacopsychiatry. 2014 Jul;47(4-5):131-40. doi: 10.1055/s-0034-1377041. Epub 2014 Jun 23.

A systematic review of calcium channel blocker use and cognitive decline/dementia in the elderly

Peters R, Booth A, Peters J.

J Hypertens. 2014 Oct;32(10):1945-57; discussion 1957-8. doi: 10.1097/HJH.0000000000000273.

Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid

Beach TG, Schneider JA, Sue LI, Serrano G, Dugger BN, Monsell SE, Kukull W.

J Neuropathol Exp Neurol. 2014 Oct;73(10):948-53. doi: 10.1097/NEN.0000000000000114.

Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer's disease--a translational perspective

Apetz N, Munch G, Govindaraghavan S, Gyengesi E.

CNS Neurol Disord Drug Targets. 2014;13(7):1175-91. doi: 10.2174/1871527313666140917110635.

Major depressive disorder and type II diabetes mellitus: mechanisms underlying risk for Alzheimer's disease

Cha DS, Carvalho AF, Rosenblat JD, Ali MM, McIntyre RS.

CNS Neurol Disord Drug Targets. 2014;13(10):1740-9. doi: 10.2174/1871527313666141130204535.

Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders

Roussotte FF, Daianu M, Jahanshad N, Leonardo CD, Thompson PM.

Brain Imaging Behav. 2014 Jun;8(2):217-233. doi: 10.1007/s11682-013-9263-y.

The prediction of response to galantamine treatment in patients with mild to moderate Alzheimer's disease

Ohnishi T, Sakiyama Y, Okuri Y, Kimura Y, Sugiyama N, Saito T, Takahashi M, Kobayashi T.

Curr Alzheimer Res. 2014 Feb;11(2):110-8. doi: 10.2174/15672050113106660167.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias